Journal of Basic and Clinical Physiology and Pharmacology,
Год журнала:
2024,
Номер
unknown
Опубликована: Сен. 19, 2024
Thyroid
hormones
(THs)
are
critical
regulators
of
muscle
metabolism
in
both
healthy
and
unhealthy
conditions.
Acting
concurrently
as
powerful
anabolic
catabolic
factors,
THs
endowed
with
a
vital
role
mass
maintenance.
As
result,
thyroid
dysfunctions
the
leading
cause
wide
range
pathologies,
globally
identified
myopathies.
Whether
wasting
is
common
feature
patients
hyperthyroidism
mainly
caused
by
THs-dependent
stimulation
proteolysis,
also
growth
often
associated
hyperthyroid
conditions,
linked
to
protein
synthesis.
Noteworthy,
hypothyroid
status
negatively
impacts
on
physiology,
causing
weakness
fatigue.
Most
these
symptoms
due
altered
balance
between
synthesis
breakdown.
Thus,
comprehensive
understanding
skeletal
turnover
might
facilitate
management
physical
discomfort
or
conditions
disease.
Herein,
we
describe
molecular
mechanisms
underlying
alteration
structure
function
atrophy
hypertrophy,
thus
providing
new
insights
for
targeted
modulation
dynamics.
Endocrine Reviews,
Год журнала:
2019,
Номер
41(2), С. 146 - 201
Опубликована: Ноя. 22, 2019
Abstract
Thyroid
hormone
transporters
at
the
plasma
membrane
govern
intracellular
bioavailability
of
thyroid
hormone.
Monocarboxylate
transporter
(MCT)
8
and
MCT10,
organic
anion
transporting
polypeptide
(OATP)
1C1,
SLC17A4
are
currently
known
as
displaying
highest
specificity
toward
hormones.
Structure-function
studies
using
homology
modeling
mutational
screens
have
led
to
better
understanding
molecular
basis
transport.
Mutations
in
MCT8
OATP1C1
been
associated
with
clinical
disorders.
Different
animal
models
provided
insight
into
functional
role
transporters,
particular
MCT8.
treatment
strategies
for
deficiency
explored,
which
analogue
therapy
is
applied
patients.
Future
may
reveal
identity
as-yet-undiscovered
transporters.
Complementary
employing
human
will
provide
further
health
disease.
Therapeutic Advances in Endocrinology and Metabolism,
Год журнала:
2020,
Номер
11
Опубликована: Янв. 1, 2020
Metabolic
syndrome
(MetS)
and
thyroid
dysfunction
are
common
in
clinical
practice.
The
objectives
of
this
review
to
discuss
some
proposed
mechanisms
by
which
dysfunctions
may
lead
MetS,
describe
the
bidirectional
relationship
between
hormones
(THs)
adiposity
finally,
resume
a
list
recent
studies
humans
that
evaluated
possible
associations
hormone
status
MetS
or
its
components.
Not
solely
THs,
but
also
metabolites
regulate
metabolic
rate,
influencing
adiposity.
enrolled
related
direct
effect
on
adenosine
triphosphate
(ATP)
utilization,
uncoupling
synthesis
ATP,
mitochondrial
biogenesis,
inotropic
chronotropic
effects.
THs
act
controlling
core
body
temperature,
appetite,
sympathetic
activity.
In
way,
function
is
affected
Leptin
one
hallmarks,
pro-inflammatory
cytokines
insulin
resistance
impact
perhaps
structure.
development
weight
gain
have
been
positively
associated
with
thyroid-stimulating
(TSH)
several
studies.
Adverse
glucose
metabolism
be
hyperthyroidism,
reduction
higher
serum
TSH,
as
do
abnormal
triglyceride
levels.
Hypo-
hyperthyroidism
blood
pressure
(BP),
consequence
genomic
nongenomic
action
vasculature
heart.
summary,
interaction
components
complex
not
fully
understood.
More
longitudinal
each
all
confounding
variables
interact
endpoints
exposure
factors
still
necessary.
Endocrinology and Metabolism,
Год журнала:
2021,
Номер
36(5), С. 952 - 964
Опубликована: Окт. 22, 2021
Thyroid
hormone
(TH)
signaling
is
strictly
regulated
by
iodothyronine
deiodinase
activity,
which
both
preserves
the
circulating
levels
of
biologically
active
triiodothyronine
(T3)
and
regulates
TH
homeostasis
at
local
level,
in
a
cell-
time-dependent
manner.
Three
deiodinases
have
been
identified—namely
1
(DIO1),
DIO2,
DIO3—that
differ
their
catalytic
properties
tissue
distribution.
The
represent
dynamic
system
that
changes
different
stages
life
according
to
functions
roles
various
cell
types
tissues.
Deiodinase
activity
level
permits
cell-targeted
fine
regulation
homeostasis,
mediating
activation
(DIO1
DIO2)
inactivation
(DIO3)
THs.
driving
force
leads
T3-target
cells
towards
customized
signaling,
takes
into
account
hormonal
tissue-specific
response.
This
review
analyzes
complex
role
physiological
pathological
contexts,
exploring
new
challenges
opportunities
deriving
from
deeper
knowledge
dynamics
underlying
functions.
International Journal of Molecular Sciences,
Год журнала:
2020,
Номер
21(11), С. 4140 - 4140
Опубликована: Июнь 10, 2020
Since
the
realization
that
cellular
homologs
of
a
gene
found
in
retrovirus
contributes
to
erythroblastosis
birds
(v-erbA),
i.e.
proto-oncogene
c-erbA
encodes
nuclear
receptors
for
thyroid
hormones
(THs),
most
interest
THs
focalized
on
their
ability
control
transcription.
It
was
found,
indeed,
that,
by
regulating
expression
many
tissues,
these
could
mediate
critical
events
both
development
and
adult
organisms.
Among
effects,
much
attention
given
increase
energy
expenditure,
they
were
early
proposed
as
anti-obesity
drugs.
However,
clinical
use
has
been
strongly
challenged
concomitant
onset
toxic
especially
heart.
Notably,
it
clearly
demonstrated
besides
direct
action
transcription
(genomic
effects),
also
have
non-genomic
mediated
cell
membrane
and/or
mitochondrial
binding
sites,
sometimes
triggered
endogenous
catabolites.
latter
molecules,
3,5-diiodo-L-thyronine
(3,5-T2)
attracting
increasing
because
some
its
metabolic
effects
are
similar
those
induced
T3,
but
seems
be
safer.
The
main
target
3,5-T2
appears
mitochondria,
hypothesized
acting
mainly
function
oxidative
stress,
might
prevent
revert
tissue
damages
hepatic
steatosis
hyper-lipid
diet,
while
concomitantly
reducing
circulating
levels
low
density
lipoproteins
(LDL)
triglycerides.
Besides
summary
concerning
general
metabolism
THs,
well
genomic
herein
we
will
discuss
resistance
possible
mechanisms
3,5-T2,
relation
drug.
Free Radical Biology and Medicine,
Год журнала:
2022,
Номер
193, С. 59 - 79
Опубликована: Окт. 4, 2022
Iodothyronine
deiodinases
(DIO)
are
a
family
of
selenoproteins
controlling
systemic
and
local
availability
the
major
thyroid
hormone
l-thyroxine
(T4),
prohormone
secreted
by
gland.
T4
is
activated
to
active
3,3'-5-triiodothyronine
(T3)
two
5'-deiodinases,
DIO1
DIO2.
DIO3,
5-deiodinase
selenoenzyme
inactivates
both
its
form
T3.
DIOs
show
species-specific
different
patterns
temporo-spatial
expression,
regulation
function
exhibit
mechanisms
reaction
inhibitor
sensitivities.
The
main
regulators
DIO
expression
status,
several
growth
factors,
cytokines
altered
pathophysiological
conditions.
Selenium
(Se)
status
has
modest
impact
on
translation.
rank
high
in
priority
selenium
supply
various
selenoproteins;
thus,
their
impaired
only
during
severe
deficiency.
variants,
polymorphisms,
SNPs
rare
mutations
have
been
identified.
Development
isozyme
selective
drugs
ongoing.
A
first
X-ray
structure
reported
for
DIO3.
This
review
focusses
biochemical
characteristics
mechanisms,
relationships
between
importance
provision
Nutritional,
pharmacological,
environmental
factors
inhibitors,
such
as
endocrine
disruptors,
functions.
The Journal of Clinical Endocrinology & Metabolism,
Год журнала:
2021,
Номер
106(11), С. e4400 - e4413
Опубликована: Июнь 29, 2021
Abstract
Introduction
Studies
comparing
levothyroxine
(LT4)
therapy
with
LT4
+
liothyronine
(LT3)
or
desiccated
thyroid
extract
(DTE)
did
not
detect
consistent
superiority
of
either
treatment.
Here,
we
investigated
these
therapies,
focusing
on
the
whole
group
LT4-treated
hypothyroid
patients,
while
also
exploring
most
symptomatic
patients.
Methodology
Prospective,
randomized,
double-blind,
crossover
study
75
patients
randomly
allocated
to
1
3
treatment
arms,
LT4,
LT3,
and
DTE,
for
22
weeks.
The
primary
outcomes
were
posttreatment
scores
36-point
symptom
questionnaire
(TSQ-36),
12-point
quality
life
general
health
(GHQ-12),
Wechsler
memory
scale-version
IV
(VMS-IV),
Beck
Depression
Inventory
(BDI).
Secondary
endpoints
included
preference,
biochemical
metabolic
parameters,
etiology
hypothyroidism,
Thr92Ala-DIO2
gene
polymorphism.
Analyses
performed
a
linear
mixed
model
using
subject
as
random
factor
fixed
effect.
Results
Serum
TSH
remained
within
reference
range
across
all
arms.
There
no
differences
secondary
outcomes,
except
minor
increase
in
heart
rate
caused
by
DTE.
Treatment
preference
was
different
there
interferences
hypothyroidism
polymorphism
outcomes.
Subgroup
analyses
1/3
revealed
strong
containing
T3,
which
improved
performance
TSQ-36,
GHQ-12,
BDI,
visual
index
(VMS-IV
component).
Conclusions
As
group,
similar
among
taking
DTE
vs
T3
LT4.
However,
those
that
preferred
responded
positively
LT3
European Journal of Endocrinology,
Год журнала:
2022,
Номер
186(5), С. R65 - R77
Опубликована: Фев. 17, 2022
Over
the
past
few
years,
growing
evidence
suggests
direct
crosstalk
between
thyroid
hormones
(THs)
and
immune
system.
Components
of
system
were
proposed
to
interfere
with
central
regulation
systemic
TH
levels.
Conversely,
THs
regulate
innate
adaptive
responses
as
cells
are
target
THs.
Accordingly,
they
express
different
components
local
action,
such
transporters
or
receptors,
but
our
picture
interplay
is
still
incomplete.
This
review
provides
a
critical
overview
current
knowledge
regarding
interaction
main
focus
on
action
within
major
cell
subsets.
Thereby,
this
aims
highlight
open
issues
which
might
help
infer
clinical
relevance
in
host
defence
context
types
diseases
infection,
ischemic
organ
injury
cancer.
Abstract
Deiodinases
modify
the
biological
activity
of
thyroid
hormone
(TH)
molecules,
ie,
they
may
activate
thyroxine
(T4)
to
3,5,3′-triiodothyronine
(T3),
or
inactivate
T3
3,3′-diiodo-L-thyronine
(T2)
T4
reverse
triiodothyronine
(rT3).
Although
evidence
deiodination
has
been
available
since
1950s,
objective
TH
metabolism
was
not
established
until
1970s.
The
modern
paradigm
considers
that
deiodinases
only
play
a
role
in
homeostasis
circulating
T3,
but
also
provide
dynamic
control
signaling:
cells
express
activating
type
2
deiodinase
(D2)
have
enhanced
signaling
due
intracellular
build-up
T3;
opposite
is
seen
3
(D3),
inactivating
deiodinase.
D2
and
D3
are
expressed
metabolically
relevant
tissues
such
as
brown
adipose
tissue,
skeletal
muscle
liver,
their
roles
investigated
using
cell,
animal,
human
models.
During
development,
expression
customize
for
each
tissue/organ
timing
intensity
signaling.
In
adult
cells,
induced
by
cyclic
adenosine
monophosphate
(cAMP),
its
invariably
associated
with
signaling,
PGC1
accelerated
energy
expenditure.
contrast,
hypoxia-inducible
factor
1α
(HIF-1a),
dampening
metabolic
rate.
coordinated
these
enzymes
adjusts
time-
tissue-specific
fashion,
affecting
pathways
health
disease
states.